Interview with Gilbert W.M. Wijntjens, Academic Medical Center Amsterdam

What is your teams’ involvement in the project?

Under supervision of prof. Dr. Jan J. Piek and Dr. Georg Fürnau, I’m the lead investigator of the microcirculation sub-study of the CULPRIT‑SHOCK trial.

What in your opinion is the innovative capacity of the CULPRIT‑SHOCK trial and its results?

The CULPRIT-SHOCK study undisputedly influenced therapeutic approaches towards cardiogenic shock complicated acute myocardial infarction.


What needs to happen in your view in cardiogenic shock to say, “a dream has come true”?

A substantial reduction in early-mortality rates for patients with acute myocardial infarction complicated by cardiogenic shock, as well as, significant improvement in quality of life after cardiogenic shock.

undefineddownload this interview


Newsletter Subscription